Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response?

被引：0
|
作者：
Genua, Marco [1 ,2 ]
Becker, Christoph [3 ]
Vetrano, Stefania [1 ,4 ]
机构：
[1] Humanitas Res Hosp, IBD Ctr, Rozzano, Italy
[2] Univ Milan, Dept Translat Med, Milan, Italy
[3] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany
[4] Humanitas Univ, Dept Biomed Sci, Milan, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷 / 03期
关键词：
CROHNS-DISEASE; CANCER CELLS; ATG16L1; NOD2; GENE; SUSCEPTIBILITY; ASSOCIATION; EVEROLIMUS;
D O I：
10.1093/ecco-jcc/jjv222
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：237 / 238
页数：2
相关论文
共 50 条
  • [1] The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
    van Schie, K. A.
    Hart, M. H.
    de Groot, E. R.
    Kruithof, S.
    Aarden, L. A.
    Wolbink, G. J.
    Rispens, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (01) : 311 - 314
  • [2] The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
    Rinaudo-Gaujous, M.
    Roblin, X.
    Marotte, H.
    Paul, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (08)
  • [3] Anti-TNF antibodies and the ischemic heart
    Frolkis, Inna
    Gurevitch, Jacob
    Yuhas, Yael
    Matsa, Menachem
    Paz, Yosef
    Yakirevich, Vladimir
    [J]. Israel Journal of Medical Sciences, 1996, 32 (Suppl):
  • [4] Mucosal Healing with Anti-TNF Antibodies
    Chevaux, Jean-Baptiste
    Vavricka, Stephan R.
    Rogler, Gerhard
    Lakatos, Peter L.
    Schoepfer, Alain
    Peyrin-Biroulet, Laurent
    [J]. DIGESTION, 2012, 86 : 16 - 22
  • [5] Gastrointestinal stability of therapeutic anti-TNF α IgG1 monoclonal antibodies
    Yadav, Vipul
    Varum, Felipe
    Bravo, Roberto
    Furrer, Esther
    Basit, Abdul W.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 502 (1-2) : 181 - 187
  • [6] INCREASED RISK OF ANTI-DRUG ANTIBODIES TO A SECOND ANTI-TNF IN PATIENTS WHO DEVELOPED ANTIBODIES TO THE FIRST ANTI-TNF
    Yanai, Henit A.
    Amir, Shira
    Avni-Biron, Irit
    Perets, Tsachi Tsadok
    Shamir, Raanan
    Dotan, Iris
    Assa, Amit
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S671 - S671
  • [7] Increased risk of anti-drug antibodies to a second anti-TNF in patients who developed antibodies to the first anti-TNF
    Yanai, H.
    Amir, S.
    Biron, I. Avni
    Perets, T. Tsadok
    Shamir, R.
    Dotan, I.
    Assa, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S439 - S439
  • [8] Relevance of anti-drug antibodies in context of supra-therapeutic anti-TNF concentrations
    Kim, J.
    Walshe, M.
    Borowski, K.
    Milgrom, R.
    Stempak, J.
    Lee, S. H.
    Croitoru, K.
    Silverberg, M. S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I933 - I934
  • [9] Successful treatment of CRPS 1 with anti-TNF
    Huygen, FJPM
    Niehof, S
    Zijlstra, FJ
    van Hagen, PM
    van Daele, PLA
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004, 27 (02) : 101 - 103
  • [10] Treatment of Kawasaki disease with anti-TNF antibodies
    Levin, Michael
    Burgner, David
    [J]. LANCET, 2014, 383 (9930): : 1700 - 1703
12345